Grant: Discovery Grants Program - Individual
Simon Fraser University
$18,000.00
Analysis and Modeling of Functional Data in Biostatistics
EF 2023-24
Résumé
The long-term goal of my new research program is to develop useful computational tools and new statistical methodologies for modeling and analysis of complex functional and longitudinal data in various areas in biostatistics, such as medical imaging, survival analysis, and clinical trial design. Over the next 5 years, my team will address three short-term objectives in three areas of application. Area 1: Novel methodological development of functional data analysis for biostatistics application. Functional data has wide a presence in biostatistics, in particular in the field of medical imaging and cancer biomarkers analysis. For example, conventional methods for functional data analysis on images of brain scans may incur high costs in terms of time and machine memory. Moreover, in cancer biomarkers analysis, trajectories are often subject to perturbation and missingness, and conventional methods for functional principal component analysis might not work effectively. To circumvent such computational difficulties, we will use a regression-based orthogonal approximation method to develop novel approaches for conducting functional principal component analysis. Area 2: Combination of functional data analysis for survival models. Existing survival models involving functional covariates typically rely on the Cox proportional hazards structure and the assumption of right censorship. Motivated by the aim of predicting the time of conversion to Alzheimer's disease from biomarker trajectories, we will combine the framework of functional regression and a generalized mixture cure model to develop several classes of functional survival models. The models will be versatile and able to handle both functional and scalar covariates, various types of censoring schemes, and both dense and sparse sampling structure. Area 3: Utilization of functional data information in trial design. This is particularly relevant for novel statistical trial designs for pandemic diseases such as the current COVID-19 pandemic. The efficacy endpoints for this type of disease is typically longitudinally ordinal. For each patient, these ordinal outcomes are observed daily across the entire timespan, forming a series of functional data objects. We will apply the methodologies of Bayesian adaptive sequential method to develop novel statistical designs for extracting information from the longitudinal data, which would enable efficient and effective testing and identification of useful treatment strategies. Taken together, the results of the proposed objectives will be of interest to researchers and developers in fields such as biostatistics and pharmaceutical statistics, in which the analysis of complex functional and longitudinal data is required. Ultimately, the analyses enabled by the developed statistical methodologies will bring new technologies that will benefit the health and well-being of Canadians and elevate Canada's reputation for statistical research on the world-stage.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2021-02963
Name nom
Shi, Haolun
Department département
Statistics and Actuarial Science
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2021
Award amount
18000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1508
Committee name en
Mathematics and Statistics
Committee name fr
Mathématiques et statistique
Area of application code
1205
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Mathematical sciences
Area of application fr
Sciences mathématiques
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Not available
Research subject en
Non disponible
Research subject fr
Non disponible
Application title
Analysis and Modeling of Functional Data in Biostatistics
Keyword
Functional data analysis; Functional principal component analysis; Imaging data; Likelihood; Missing data; Robust Regression; Smoothing Spline
Application summary
The long-term goal of my new research program is to develop useful computational tools and new statistical methodologies for modeling and analysis of complex functional and longitudinal data in various areas in biostatistics, such as medical imaging, survival analysis, and clinical trial design. Over the next 5 years, my team will address three short-term objectives in three areas of application. Area 1: Novel methodological development of functional data analysis for biostatistics application. Functional data has wide a presence in biostatistics, in particular in the field of medical imaging and cancer biomarkers analysis. For example, conventional methods for functional data analysis on images of brain scans may incur high costs in terms of time and machine memory. Moreover, in cancer biomarkers analysis, trajectories are often subject to perturbation and missingness, and conventional methods for functional principal component analysis might not work effectively. To circumvent such computational difficulties, we will use a regression-based orthogonal approximation method to develop novel approaches for conducting functional principal component analysis. Area 2: Combination of functional data analysis for survival models. Existing survival models involving functional covariates typically rely on the Cox proportional hazards structure and the assumption of right censorship. Motivated by the aim of predicting the time of conversion to Alzheimer's disease from biomarker trajectories, we will combine the framework of functional regression and a generalized mixture cure model to develop several classes of functional survival models. The models will be versatile and able to handle both functional and scalar covariates, various types of censoring schemes, and both dense and sparse sampling structure. Area 3: Utilization of functional data information in trial design. This is particularly relevant for novel statistical trial designs for pandemic diseases such as the current COVID-19 pandemic. The efficacy endpoints for this type of disease is typically longitudinally ordinal. For each patient, these ordinal outcomes are observed daily across the entire timespan, forming a series of functional data objects. We will apply the methodologies of Bayesian adaptive sequential method to develop novel statistical designs for extracting information from the longitudinal data, which would enable efficient and effective testing and identification of useful treatment strategies. Taken together, the results of the proposed objectives will be of interest to researchers and developers in fields such as biostatistics and pharmaceutical statistics, in which the analysis of complex functional and longitudinal data is required. Ultimately, the analyses enabled by the developed statistical methodologies will bring new technologies that will benefit the health and well-being of Canadians and elevate Canada's reputation for statistical research on the world-stage.